Objectives: Gestational diabetes mellitus (GDM) is a common disorder in pregnant women. Long noncoding RNA (lncRNA) is a fundamental mediator in the pathogenesis of GDM. The study aimed to detect the clinical importance of lncRNA OIP5-AS1 and its underlying regulation on trophoblast cells. Design: The expression of OIP5-AS1 and miR-137-3p was assessed by the quantitative real-time PCR technique. The prognostic effect of OIP5-AS1 was analyzed by the receiver operating characteristic curve. The influences of OIP5-AS1 on cells were indicated by cell counting kit-8, transwell experiments, and flow cytometry. Luciferase activity assay was used to identify the target relationships among OIP5-AS1, miR-137-3p, and EZH2. Participants: A total of 75 pregnant women with GDM who were treated in the Dongying People’s Hospital were selected as the GDM group. Besides, 72 pregnant women with non-GDM who underwent physical examination in the same hospital were selected as the control group. Results: Decreased expression of OIP5-AS1 was confirmed in GDM patients, and the level of OIP5-AS1 could be used as a basis for evaluating GDM patients. Upregulation of OIP5-AS1 ameliorated the viability, migration, invasion, and apoptosis of HG-stimulated HTR-8/SVneo cells by sponging miR-137-3p. EZH2 was a direct target of miR-137-3p. Conclusions: OIP5-AS1 level decreased in women with GDM. OIP5-AS1 appeared to help separating GDM patients from healthy pregnant women. The OIP5-AS1/miR-137-3p/EZH2 pathway could exert its function on HG-induced HTR-8/SVneo models.

1.
Wu
H
,
Wu
S
,
Zhu
Y
,
Ye
M
,
Shen
J
,
Liu
Y
,
Hsa_circRNA_0054633 is highly expressed in gestational diabetes mellitus and closely related to glycosylation index
.
Clin Epigenetics
.
2019 Feb 8
;
11
(
1
):
22
. .
2.
Liu
L
,
Hu
J
,
Wang
N
,
Liu
Y
,
Wei
X
,
Gao
M
,
A novel association of CCDC80 with gestational diabetes mellitus in pregnant women: a propensity score analysis from a case-control study
.
BMC Pregnancy Childbirth
.
2020 Jan 28
;
20
(
1
):
53
. .
3.
Zhang
M
,
Zhou
Y
,
Zhong
J
,
Wang
K
,
Ding
Y
,
Li
L
,
Quality appraisal of gestational diabetes mellitus guidelines with AGREE II: a systematic review
.
BMC Pregnancy Childbirth
.
2019 Dec 5
;
19
(
1
):
478
. .
4.
Chen
SH
,
Liu
XN
,
Peng
Y
.
MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus
.
J Cell Mol Med
.
2019 Sep
;
23
(
9
):
5895
906
. .
5.
Wang
B
,
Xue
X
.
Investigations of associations between seven gene polymorphisms and gestational diabetes mellitus: evidence from a meta-analysis
.
Gynecol Obstet Invest
.
2020
;
85
(
3
):
229
36
. .
6.
Zhang
X
,
Xiao
Y
.
The association between trimester-specific weight gain and severe preeclampsia/adverse perinatal outcome in gestational diabetes mellitus complicated by preeclampsia: a retrospective case study
.
Diabetes Ther
.
2019 Apr
;
10
(
2
):
725
34
. .
7.
Su
M
,
Nie
Y
,
Shao
R
,
Duan
S
,
Jiang
Y
,
Wang
M
,
Diversified gut microbiota in newborns of mothers with gestational diabetes mellitus
.
PLoS One
.
2018
;
13
(
10
):
e0205695
. .
8.
Liu
W
,
Huang
Z
,
Tang
S
,
Zhang
Z
,
Yu
Q
,
He
J
.
Changes of serum sex hormone-binding globulin, homocysteine, and hypersensitive CRP levels during pregnancy and their relationship with gestational diabetes mellitus
.
Gynecol Obstet Invest
.
2021
;
86
(
1–2
):
193
9
. .
9.
Wu
L
,
Fang
C
,
Zhang
J
,
Ye
Y
,
Zhao
H
.
The association between maternal/fetal insulin receptor substrate 1 gene polymorphism rs1801278 and gestational diabetes mellitus in a Chinese population
.
Gynecol Obstet Invest
.
2021
;
86
(
1–2
):
177
84
. .
10.
Zhang
M
,
Wang
G
,
Zhu
Y
,
Wu
D
.
Characterization of BRCA1/2-directed ceRNA network identifies a novel three-lncRNA signature to predict prognosis and chemo-response in ovarian cancer patients with wild-type BRCA1/2
.
Front Cell Dev Biol
.
2020
;
8
:
680
. .
11.
Filardi
T
,
Catanzaro
G
,
Mardente
S
,
Zicari
A
,
Santangelo
C
,
Lenzi
A
,
Non-coding RNA: role in gestational diabetes pathophysiology and complications
.
Int J Mol Sci
.
2020 Jun 4
;
21
(
11
):
21
. .
12.
Wang
S
,
Lin
Y
,
Zhong
Y
,
Zhao
M
,
Yao
W
,
Ren
X
,
The long noncoding RNA HCG18 participates in PM2.5-mediated vascular endothelial barrier dysfunction
.
Aging
.
2020 Nov 16
;
12
(
23
):
23960
73
. .
13.
Cao
M
,
Zhang
L
,
Lin
Y
,
Li
Z
,
Xu
J
,
Shi
Z
,
Differential mRNA and long noncoding RNA expression profiles in umbilical cord blood exosomes from gestational diabetes mellitus patients
.
DNA Cell Biol
.
2020 Nov
;
39
(
11
):
2005
16
. .
14.
Zhang
Y
,
Wu
H
,
Wang
F
,
Ye
M
,
Zhu
H
,
Bu
S
.
Long non-coding RNA MALAT1 expression in patients with gestational diabetes mellitus
.
Int J Gynaecol Obstet
.
2018 Feb
;
140
(
2
):
164
9
. .
15.
Ye
HH
,
Yang
SH
,
Zhang
Y
.
MEG3 damages fetal endothelial function induced by gestational diabetes mellitus via AKT pathway
.
Eur Rev Med Pharmacol Sci
.
2018 Dec
;
22
(
24
):
8553
60
. .
16.
Esfandi
F
,
Kholghi Oskooei
V
,
Taheri
F
,
Kiani
A
,
Taheri
M
,
Ghafouri-Fard
S
.
Expression analysis of OIP5-AS1 in non-small cell lung cancer
.
Klin Onkol
.
2018 Summer
;
31
(
4
):
260
3
. .
17.
Niu
X
,
Pu
S
,
Ling
C
,
Xu
J
,
Wang
J
,
Sun
S
,
lncRNA Oip5-as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR-29a to activate the SIRT1/AMPK/PGC1α pathway
.
Cell Prolif
.
2020 Jun
;
53
(
6
):
e12818
. .
18.
Xie
W
,
Wu
D
,
Ren
Y
,
Jiang
Y
,
Zhang
H
,
Yang
S
,
OIP5-AS1 attenuates microangiopathy in diabetic mouse by regulating miR-200b/ACE2
.
World Neurosurg
.
2020 Jul
;
139
:
e52
60
. .
19.
American Diabetes Association
.
2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018
.
Diabetes Care
.
2018 Jan
;
41
(
Suppl 1
):
S13
27
. .
20.
Wu
Z
,
Mao
W
,
Yang
Z
,
Lei
D
,
Huang
J
,
Fan
C
,
Knockdown of CYP1B1 suppresses the behavior of the extravillous trophoblast cell line HTR-8/SVneo under hyperglycemic condition
.
J Matern Fetal Neonatal Med
.
2021 Feb
;
34
(
4
):
500
11
. .
21.
Wang
H
,
Zhou
W
,
She
G
,
Yu
B
,
Sun
L
.
Downregulation of hsa_circ_0005243 induces trophoblast cell dysfunction and inflammation via the β-catenin and NF-κB pathways
.
Reprod Biol Endocrinol
.
2020 May 20
;
18
(
1
):
51
. .
22.
Zhou
J
,
Bai
J
,
Guo
Y
,
Fu
L
,
Xing
J
.
Higher levels of triglyceride, fatty acid translocase, and toll-like receptor 4 and lower level of HDL-C in pregnant women with GDM and their close correlation with neonatal weight
.
Gynecol Obstet Invest
.
2021
;
86
(
1–2
):
48
54
. .
23.
Li
C
,
Qiao
B
,
Zhou
Y
,
Qi
W
,
Ma
C
,
Zheng
L
.
Association of estrogen receptor α gene polymorphism and its expression with gestational diabetes mellitus
.
Gynecol Obstet Invest
.
2020
;
85
(
1
):
26
33
. .
24.
He
Z
,
Tang
Y
,
Xie
H
,
Lin
Y
,
Liang
S
,
Xu
Y
,
Economic burden of IADPSG gestational diabetes diagnostic criteria in China: propensity score matching analysis from a 7-year retrospective cohort
.
BMJ Open Diabetes Res Care
.
2020 Aug
;
8
(
1
):
e001538
. .
25.
Wang
X
,
Liu
W
,
Chen
H
,
Chen
Q
.
Comparison of insulin, metformin, and glyburide on perinatal complications of gestational diabetes mellitus: a systematic review and meta-analysis
.
Gynecol Obstet Invest
.
2021
;
86
(
3
):
218
30
. .
26.
Guan
CY
,
Tian
S
,
Cao
JL
,
Wang
XQ
,
Ma
X
,
Xia
HF
.
Down-regulated miR-21 in gestational diabetes mellitus placenta induces PPAR-α to inhibit cell proliferation and infiltration
.
Diabetes Metab Syndr Obes
.
2020
;
13
:
3009
34
. .
27.
Li
YX
,
Long
DL
,
Liu
J
,
Qiu
D
,
Wang
J
,
Cheng
X
,
Gestational diabetes mellitus in women increased the risk of neonatal infection via inflammation and autophagy in the placenta
.
Medicine
.
2020 Oct 2
;
99
(
40
):
e22152
. .
28.
Gao
Y
,
Luo
X
,
Zhang
J
.
Activation of LncRNA FOXD2-AS1 by H3K27 acetylation regulates VEGF-A expression by sponging miR-205-5p in recurrent pterygium
.
J Cell Mol Med
.
2020 Oct 23
;
24
(
24
):
14139
51
. .
29.
Tang
L
,
Li
P
,
Li
L
.
Whole transcriptome expression profiles in placenta samples from women with gestational diabetes mellitus
.
J Diabetes Investig
.
2020 Sep
;
11
(
5
):
1307
17
. .
30.
Ryan
EA
,
Enns
L
.
Role of gestational hormones in the induction of insulin resistance
.
J Clin Endocrinol Metab
.
1988 Aug
;
67
(
2
):
341
7
. .
31.
Carrasco-Wong
I
,
Moller
A
,
Giachini
FR
,
Lima
VV
,
Toledo
F
,
Stojanova
J
,
Placental structure in gestational diabetes mellitus
.
Biochim Biophys Acta Mol Basis Dis
.
2020 Feb 1
;
1866
(
2
):
165535
. .
32.
Xian
S
,
Zhang
Y
,
Wang
L
,
Yao
F
,
Ding
J
,
Wang
Y
,
INO80 participates in the pathogenesis of recurrent miscarriage by epigenetically regulating trophoblast migration and invasion
.
J Cell Mol Med
.
2021 Apr
;
25
(
8
):
3885
97
. .
33.
Li
J
,
Cui
Z
,
Li
H
,
Lv
X
,
Gao
M
,
Yang
Z
,
Long non-coding RNA HOTAIR polymorphism and susceptibility to cancer: an updated meta-analysis
.
Environ Health Prev Med
.
2018 Feb 20
;
23
(
1
):
8
. .
34.
Zhang
Y
,
Qu
L
,
Ni
H
,
Wang
Y
,
Li
L
,
Yang
X
,
Expression and function of lncRNA MALAT1 in gestational diabetes mellitus
.
Adv Clin Exp Med
.
2020 Aug
;
29
(
8
):
903
10
. .
35.
Zhang
H
.
Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus
.
Exp Ther Med
.
2019 Nov
;
18
(
5
):
3699
706
. .
36.
Wang
Y
,
Wang
H
,
Ruan
J
,
Zheng
W
,
Yang
Z
,
Pan
W
.
Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression
.
Cancer Cell Int
.
2020
;
20
:
155
. .
37.
Sun
H
,
Wang
C
,
Zhou
Y
,
Cheng
X
.
Long noncoding RNA OIP5-AS1 overexpression promotes viability and inhibits high glucose-induced oxidative stress of cardiomyocytes by targeting microRNA-34a/SIRT1 axis in diabetic cardiomyopathy
.
Endocr Metab Immune Disord Drug Targets
.
2020 Dec 29
. Epub ahead of print.
38.
Zheng
D
,
Wang
B
,
Zhu
X
,
Hu
J
,
Sun
J
,
Xuan
J
,
LncRNA OIP5-AS1 inhibits osteoblast differentiation of valve interstitial cells via miR-137/TWIST11 axis
.
Biochem Biophys Res Commun
.
2019 Apr 16
;
511
(
4
):
826
32
. .
39.
Sun
X
,
Tian
C
,
Zhang
H
,
Han
K
,
Zhou
M
,
Gan
Z
,
Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma
.
Biomed Pharmacother
.
2020 Aug
;
128
:
110201
. .
40.
Peng
HY
,
Li
MQ
,
Li
HP
.
MiR-137 restricts the viability and migration of HTR-8/SVneo cells by downregulating FNDC5 in gestational diabetes mellitus
.
Curr Mol Med
.
2019
;
19
(
7
):
494
505
. .
41.
Guo
L
,
Chen
J
,
Liu
D
,
Liu
L
.
OIP5-AS1/miR-137/ZNF217 axis promotes malignant behaviors in epithelial ovarian cancer
.
Cancer Manag Res
.
2020
;
12
:
6707
17
. .
42.
Liu
X
,
Cui
L
,
Hua
D
.
Long noncoding RNA XIST regulates miR-137-EZH2 axis to promote tumor metastasis in colorectal cancer
.
Oncol Res
.
2018 Dec 27
;
27
(
1
):
99
106
. .
43.
Liao
X
,
Zhou
Z
,
Zhang
X
.
Effects of miR-195-5p on cell proliferation and apoptosis in gestational diabetes mellitus via targeting EZH2
.
Mol Med Rep
.
2020 Aug
;
22
(
2
):
803
9
. .
44.
Floris
I
,
Descamps
B
,
Vardeu
A
,
Mitić
T
,
Posadino
AM
,
Shantikumar
S
,
Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2
.
Arterioscler Thromb Vasc Biol
.
2015 Mar
;
35
(
3
):
664
74
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.